Imagion Biosystems Limited (ASX:IBX)
0.0250
0.00 (0.00%)
Feb 11, 2026, 2:32 PM AEST
Imagion Biosystems Revenue
Imagion Biosystems had revenue of 25.73K AUD in the half year ending June 30, 2025, a decrease of -96.27%. This brings the company's revenue in the last twelve months to 1.06M, down -82.15% year-over-year. In the year 2024, Imagion Biosystems had annual revenue of 2.67M, down -46.38%.
Revenue (ttm)
1.06M
Revenue Growth
-82.15%
P/S Ratio
11.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.67M | -2.31M | -46.38% |
| Dec 31, 2023 | 4.97M | 1.90M | 61.87% |
| Dec 31, 2022 | 3.07M | 215.36K | 7.54% |
| Dec 31, 2021 | 2.86M | 158.60K | 5.88% |
| Dec 31, 2020 | 2.70M | 206.96K | 8.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Healius | 1.34B |
| Australian Clinical Labs | 741.27M |
| Integral Diagnostics | 627.22M |
| Monash IVF Group | 271.92M |
| Genetic Signatures | 19.75M |
| Microba Life Sciences | 15.67M |
| Cryosite | 14.12M |
| Genetic Technologies | 9.17M |